SGP — SpyGlass Pharma Share News
0.000.00%
Last trade - 00:00- $826.83m
- $592.65m
SpyGlass Pharma Q2 net loss widens on higher expenses
Brief: Spyglass Pharma Inc - BIM-Iol System Phase 3 Trial Enrollment Expected To Complete In 2027
Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO (updated)
NASDAQ RESUMED AT 01:46 PM
U.S. STOCKS ON THE MOVE-SpyGlass, Agomab, Piper Sandler, Molina
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:36 PM
SpyGlass surges in Nasdaq debut after $150 million IPO
NASDAQ RESUMED AT 12:13 PM
SpyGlass poised to open higher in Nasdaq debut after $150 million IPO
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
Brief: Spyglass Pharma Announces Pricing Of IPO At $16.00 Per Share